Tech Company Financing Transactions
C2N Funding Round
C2N, based in St. Louis, secured $15 million from GHR Foundation.
Transaction Overview
Company Name
Announced On
9/30/2024
Transaction Type
Venture Equity
Amount
$15,000,000
Round
Undisclosed
Investors
GHR Foundation (Lead Investor)
Proceeds Purpose
The company intends to use the funds for new tests specific to tau tangle pathology.
Company Information
Company Status
Private & Independent
Industry
Real Estate
Mailing Address
4340 Duncan Avenue
St. Louis, MO 63110
USA
St. Louis, MO 63110
USA
Phone
Website
Email Address
Overview
C2N is a specialty diagnostics company providing exceptional laboratory services and products in the field of brain health. C2N's high-resolution mass spectrometry-based biomarker products and services are used for: clinical decision-making to improve patient care, including diagnosis and treatment monitoring; maximizing the quality and efficiency of clinical trials that test novel treatments for neurodegeneration; and providing innovative tools to help healthcare researchers better understand novel mechanisms of disease, identify new treatment targets, and conduct important epidemiological studies to improve global public health.
Management Team
Title
Name
Email & Social
Browse more venture capital transactions:
Prev: 9/30/2024: Podeo venture capital transaction
Next: 9/30/2024: Mindpeak venture capital transaction
Share this article
About Database of VC Transactions
We report on all VC transactions involving tech companies. All VC database entries reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs